When defining the term gold standard, the most appropriate definition is “a benchmark test that is the best available under reasonable conditions”. Rafal Ziecina at Worldwide Clinical Trials demonstrates how when considering this definition, it becomes clear that non-invasive imaging is replacing liver biopsy as the gold standard for evaluation of fibrosis in non-alcoholic fatty liver disease (NAFLD).

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2020/02/Is-Liver-Biopsy-a-Gold-or-an-Old-Standard.pdf” width=”100%” height=”900px” style=”border:0;”]